Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2014

Stockholders' Equity Note [Abstract]

Summary of activity under stock incentive plans

A summary of the activity under the Endo 2000, 2004, 2007, and 2010 Stock Incentive Plans and the Endo Assumed Stock Incentive Plan for the three months ended March 31, 2014 is presented below:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding as of January 1, 2014	4,245,789		$	29.30
Granted	487,521		$	79.58
Exercised	(771,960	)	$	27.97
Forfeited	(221,049	)	$	32.28
Expired	(14,288	)	$	24.53
Outstanding as of March 31, 2014	3,726,013		$	35.99	5.67	$	124,242,124
Vested and expected to vest as of March 31, 2014	3,515,383		$	35.20	5.60	$	119,462,871
Exercisable as of March 31, 2014	2,025,802		$	27.19	4.57	$	82,254,814

Stock option assumption

The weighted average grant date fair value of the options granted in the three months ended March 31, 2014 and 2013 was $21.31 and $9.33 per option, respectively, determined using the following assumptions:

	March 31, 2014		March 31, 2013
Average expected term (years)	4.0		5.0
Risk-free interest rate	1.1	%	0.8	%
Dividend yield	—		—
Expected volatility	32	%	33	%

Summary of restricted stock units activity

A summary of our restricted stock units for the three months ended March 31, 2014 is presented below:

	Number of Shares		Aggregate Intrinsic Value
Outstanding as of January 1, 2014	2,262,428
Granted	470,386
Forfeited	(130,793	)
Vested	(754,289	)
Outstanding as of March 31, 2014	1,847,732		$	125,257,752
Vested and expected to vest as of March 31, 2014	1,571,091		$	101,097,755

Summary of restricted stock activity

A summary of our restricted stock awards for the three months ended March 31, 2014 is presented below:

	Number of Shares		Weighted Average Fair Value Per Share		Aggregate Intrinsic Value
Non-vested as of January 1, 2014	27,492		$	33.91
Granted	—		$	—
Forfeited	(1,507	)	$	35.89
Vested	(5,872	)	$	33.60	$	403,113
Non-vested as of March 31, 2014	20,113		$	33.85

Schedule of changes in stockholders' equity

The following table displays a reconciliation of our beginning and ending balances in shareholders' equity for the three months ended March 31, 2014 (dollars in thousands):

	Attributable to:
	Endo International plc			Noncontrolling interests			Total Shareholders’ Equity
Shareholders’ equity at January 1, 2014	$	526,018		$	59,198		$	585,216
Net (loss) income	(436,912		)	3,634			(433,278		)
Other comprehensive income	4,737			—			4,737
Compensation related to share-based awards	7,595			—			7,595
Tax withholding for restricted shares	(21,475		)	—			(21,475		)
Exercise of options	21,593			—			21,593
Distributions to noncontrolling interests	—			(4,963		)	(4,963		)
Buy-out of noncontrolling interests, net of contributions	—			(82		)	(82		)
Addition of Paladin noncontrolling interests due to acquisition	—			69,600			69,600
Removal of HealthTronics, Inc. noncontrolling interests due to disposition	—			(57,359		)	(57,359		)
Ordinary shares issued in connection with the Paladin acquisition	2,844,279			—			2,844,279
Other	21,500			—			21,500
Shareholders’ equity at March 31, 2014	$	2,967,335		$	70,028		$	3,037,363

As part of the reorganization upon consummation of the Paladin acquisition, EHSI Common stock and Treasury stock in the amounts of $1.5 million and $763.1 million were retired and reclassified into Additional paid-in capital.

The following table displays a reconciliation of our beginning and ending balances in shareholders' equity for the three months ended March 31, 2013 (dollars in thousands):

	Attributable to:
	Endo International plc			Noncontrolling interests			Total Shareholders’ Equity
Shareholders’ equity at January 1, 2013	$	1,072,856		$	60,350		$	1,133,206
Net income	15,349			11,254			26,603
Other comprehensive loss	(2,364		)	—			(2,364		)
Compensation related to share-based awards	15,331			—			15,331
Tax withholding for restricted shares	—			—			—
Exercise of options	12,826			—			12,826
Ordinary shares issued from treasury, net of ordinary shares purchased	1,557			—			1,557
Distributions to noncontrolling interests	—			(12,832		)	(12,832		)
Buy-out of noncontrolling interests, net of contributions	—			(1,406		)	(1,406		)
Other	(1,184		)	—			(1,184		)
Shareholders’ equity at March 31, 2013	$	1,114,371		$	57,366		$	1,171,737